MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI)

Historical Holders from Q4 2020 to Q3 2025

Symbol
MRVI on Nasdaq
CUSIP
56600D107
Type / Class
Equity / Class A Common Stock, par value $0.01 per share
Shares outstanding
145M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
131M
Holdings value
$375M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
155
Number of buys
72
Number of sells
-62
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
12 West Capital Management LP 8.2% $24.3M 11.6M 12 West Capital Management LP Dec 31, 2024
FELDMAN STUART 6.17% +28% $25.7M $5.96M 8.94M +30.2% Stuart Feldman Sep 30, 2025
BlackRock, Inc. 5.9% $24.6M 8.58M BlackRock, Inc. Sep 30, 2025
VANGUARD GROUP INC 4.92% -22.7% $20.5M -$6.47M 7.13M -24% The Vanguard Group Sep 30, 2025

Institutional Holders of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 131M $375M +$4.44M $2.87 155
2025 Q2 130M $312M +$3.79M $2.41 147
2025 Q1 129M $284M -$79.9M $2.21 183
2024 Q4 140M $761M -$45.9M $5.45 179
2024 Q3 144M $1.2B -$27.8M $8.31 216
2024 Q2 147M $1.05B +$79.3M $7.16 199
2024 Q1 135M $1.17B +$22.5M $8.67 206
2023 Q4 400K $2.63M +$1.13M $6.55 4
2023 Q3 134M $1.34B +$77M $10.00 198
2023 Q2 126M $1.57B -$35.4M $12.43 213
2023 Q1 128M $1.79B +$17M $14.01 208
2022 Q4 127M $1.81B -$136M $14.31 199
2022 Q3 129M $3.29B +$11.7M $25.53 181
2022 Q2 131M $3.72B +$80.6M $28.41 198
2022 Q1 128M $4.51B -$20M $35.27 224
2021 Q4 128M $5.36B -$43.6M $41.90 216
2021 Q3 127M $6.25B +$684M $49.08 218
2021 Q2 114M $4.77B +$730M $41.73 190
2021 Q1 98.3M $3.5B +$129M $35.64 138
2020 Q4 97.4M $2.73B +$1.94B $28.05 112